Sharon Shacham, President & CSO at Karyopharm Therapeutics Inc. (KPTI), sold 15,000 shares at $18.65 ($290K) on 2020-05-15, disclosed to the SEC on 2020-05-19.
Open-market sale of $290k KPTI by President & CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.65 | 7,500 | $140K | 48.3% |
| 2 | $20.00 | 7,500 | $150K | 51.7% |
| Total | $19.32 avg | 15,000 | $290K | 100% |
| Filing → |
| KPTI | SELL | 2022-02-09 | $266K | — | Filing → |
| KPTI | SELL | 2021-03-23 | $50K | — | Filing → |
| KPTI | SELL | 2021-02-22 | $282K | — | Filing → |